Navigation Links
Leading Animal Stem Cell Developer MediVet-America Achieves Significant Business Growth Milestones in First Year
Date:2/4/2011

NICHOLASVILLE, Ky., Feb. 4, 2011 /PRNewswire/ -- MediVet-America, the leading developer of in-clinic stem cell regenerative therapy for animals suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries and similar ailments, ended its first year of business having achieved record advances in size and scope.

Using MediVet-America's new Adipose-Derived Stem Cell Procedure Kit and equipment, veterinary practitioners perform the drug-free procedure entirely in their own clinics, in one day, more quickly, effectively and economically than first-generation animal stem cell therapy.

This new treatment, previously only available in Australia and New Zealand, was launched in the United States, Canada, South America and Hong Kong in 2010.

Over the past year, MediVet-America has signed agreements with more than 100 leading veterinarians and clinics, 12 distributor territories in 20 states and four provinces in Canada, providing vets with the ability to perform in-house stem cell procedures that can lengthen and rejuvenate the quality of life for adult dogs, cats and horses experiencing lameness, pain, and a restricted range of motion.  Before stem cell therapy, veterinarians were limited to prescribing anti-inflammatory medicine or performing expensive surgery.

In December, the company launched MediVet Lab Services in Lexington, KY, that provides technical support for in-clinic animal stem cell procedures, regional and national Adipose Stem Cell Processing, Cryogenic Banking Services, Autologous Conditional Serum Processing, and Cell Counting Services for stem cell treatments.

MediVet-America Managing Director Jeremy Delk envisions opening additional labs throughout the U.S. that will also provide an interactive web site with an online vet certification program and a quality assurance/control program encompassing cell counts and sterility.

"We experienced a tremendous year of growth in all areas of our business," said Delk.  "We're overwhelmed by the enthusiastic response we've received from pet owners and veterinarians around the world, and we're deeply honored by the pet industry's acknowledgement of our services.

"Excitement for the technology continues to grow; we are now seeing stem cell procedures happening every day for the past two months."

ABOUT MEDIVET-AMERICAA research and development company and global leader in veterinary stem cell technology, MediVet-America provides innovative cell applications for the therapeutic care of animals.  Headquartered in Nicholasville, Kentucky, MediVet-America develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. www.MediVet-America.comCONTACT:

Dick RobertsRoberts Communicationso:  412-535-5000  c:  412-721-7400droberts@rob-com.com
'/>"/>

SOURCE MediVet-America
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services
2. Leading Scientific Laboratory Offers New Methods for Metals Testing
3. Leading Dental Stem Cell and Regenerative Medicine Researcher Dr. George Huang Joins StemSaves Science Advisory Council
4. Elsevier brings together leading experts from around the world for DIAMOND 2011 conference
5. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
6. Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players
7. UBM Medica Acquires Leading Online Community OBGYN.net
8. Molecular Detections Detect-Ready™ MRSA Assay Demonstrates Strong Performance In Independent Comparative Study From Leading UK Hospital
9. Leading Journal Turns Up the Heat on Cutting-Edge Breast Cancer Treatment
10. Waters Corporation and UCLA to Convene Leading Life Scientists
11. Viscira Delivers Key Presentation to Pharmaceutical Marketing Professionals at Leading Digital Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):